Home Magazines Editors-in-Chief FAQs Contact Us

Why are we failing to cure so many cases of invasive lobular breast cancer?


Journal of Cancer Prevention & Current Research
László Tabár, Peter B Dean, Li-Sheng Chen, Olga Puchkova, Amy Ming-Fang Yen,Hsiu-Hsi Chen, F Lee Tucker, Robert A Smith,Katalin Ormándi, Orsolya Oláh-Németh, Zoltán Veréb, András Vörös, Renáta Bozó

PDF Full Text

Abstract

Review evidence for the site of origin of diffuse invasive lobular carcinoma (ILC), supported by cell culture results. Describe two distinct forms of classic ILC, which have vastly different long-term outcomes. Recognition of the hybrid (stem) cell origin of classic ILC could foster improvement of its currently inadequate management.

Keywords

breast cancer, invasive lobular carcinoma, imaging biomarkers, molecular biomarkers, long-term outcome.

Testimonials